CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Balance Sheet
NASDAQ:CLOV - Nasdaq - US18914F1030 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 155.44M | N/A | 122.86M | 103.80M | 300.00M | |||
| Marketable Securities | 4.66M | N/A | 175.45M | 331.50M | 327.90M | |||
| Receivables | 53.53M | 52.00M | 92.00M | 147.20M | 62.30M | |||
| Other Current Assets | 117.78M | 70.00M | 37.00M | 42.50M | 62.30M | |||
| Total Current Assets | 331.41M | 343.00M | 428.00M | 625.00M | 752.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.03M | 5.31M | 8.46M | 9.80M | 7.70M | |||
| Investments And Advances | 230.75M | 216.00M | 121.00M | 138.10M | 175.90M | |||
| Intangibles | 2.99M | 2.99M | 2.99M | 20.00M | 4.20M | |||
| Other Non-Current Assets | 13.54M | 13.00M | 10.00M | 15.70M | 10.40M | |||
| Total Non-Current Assets | 252.31M | 238.00M | 143.00M | 183.60M | 198.30M | |||
| TOTAL ASSETS | 583.72M | 581.00M | 571.00M | 808.60M | 950.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 30.52M | 19.00M | 23.00M | 25.80M | 18.20M | |||
| Accounts Payable | 30.55M | N/A | 37.18M | 32.40M | 28.10M | |||
| Other Current Liabilities | 154.58M | 160.00M | 201.00M | 373.30M | 326.30M | |||
| Total Current Liabilities | 215.65M | 214.00M | 261.00M | 431.50M | 372.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 19.90M | |||
| Other Non-Current Liabilities | 31.99M | 26.00M | 23.00M | 20.20M | 18.90M | |||
| Total Non-Current Liabilities | 31.99M | 26.00M | 23.00M | 20.20M | 42.80M | |||
| TOTAL LIABILITIES | 247.64M | 240.00M | 284.00M | 451.70M | 415.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.20B | -2.20B | -2.16B | -1.95B | -1.62B | |||
| Additional Paid In Capital | 2.60B | 2.58B | 2.46B | 2.32B | 2.15B | |||
| Minority Interest | N/A | N/A | N/A | 0.00 | 3.90M | |||
| Common Shares | 50.00K | 50.00K | 50.00K | 0.00 | 0.00 | |||
| Treasury Stock | -62.95M | -31.00M | -13.00M | -6.50M | -100.00K | |||
| Other Shareholders' Equity | -74.00K | -1.58M | -2.37M | -9.40M | -1.90M | |||
| Shares Outstanding | 506.54M | 504.00M | 489.00M | 478.40M | 470.90M | |||
| Tangible Book Value per Share | 0.66 | 0.67 | 0.58 | 0.70 | 1.13 | |||
| Total Shareholders' Equity | 336.07M | 341.00M | 286.00M | 356.90M | 535.40M | |||
| TOTAL LIABILITIES AND EQUITY | 583.72M | 581.00M | 571.00M | 808.60M | 950.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.04 | |||
| Current Ratio | 1.54 | 1.60 | 1.64 | 1.45 | 2.02 | |||
| Return On Assets (ROA) | -4.30% | -7.40% | -37.37% | -41.90% | -61.82% | |||
| Return On Equity (ROE) | -7.47% | -12.61% | -74.60% | -94.93% | -109.79% | |||
All data in USD , ROIC based on taxRate of 0.21